10x Genomics, Inc. - TXG
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | ARK Investment Management LLC | 8.56% | 10,003,058 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Catherine D. Wood | 8.56% | 10,003,058 | View |
| Apr 29, 2026 | SCHEDULE 13G | Vanguard Capital Management | 5.24% | 6,166,597 | View |
| Apr 28, 2026 | SCHEDULE 13G | Vanguard Portfolio Management | 5.93% | 6,981,683 | View |
| Mar 25, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 24, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 06, 2026 | SCHEDULE 13G/A | FMR LLC | 15.6% | 18,543,562 | View |
| Mar 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 15.6% | 18,543,562 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.